ConductScience.org, home

Gene · 316

Papers2,549

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

341 to 360 of 2,549

Download this page as JSON
TitleJournalYearPMIDFound bySource
Identification of Biological Functions and Prognostic Value of NNMT in Oral Squamous Cell Carcinoma.Biomolecules202236291696PubTator, text miningPubMed
Advances in Novel Nanomaterial-Based Optical Fiber Biosensors-A Review.Biosensors (Basel)202236290980PubTator, text miningPubMed
Development of a joint diagnostic model of thyroid papillary carcinoma with artificial neural network and random forest.Front Genet202236276977PubTator, text miningPubMed
Considerations into pharmacogenomics of COVID-19 pharmacotherapy: Hope, hype and reality.Pulm Pharmacol Ther202236265833PubTator, text miningPubMed
Combined inhibition of PARP and EZH2 for cancer treatment: Current status, opportunities, and challenges.Front Pharmacol202236263120PubTator, text miningPubMed
Effects of Genetic Variants in the Nicotine Metabolism Pathway on Smoking Cessation.Genet Res (Camb)202236245555PubTator, text miningPubMed
Low-Dose Azathioprine in Combination with Allopurinol: The Past, Present and Future of This Useful Duo.Dig Dis Sci202236242689PubTator, text miningPubMed
Effect of Neonicotinoid Pesticides on Japanese Water Systems: Review with Focus on Reproductive Toxicity.Int J Mol Sci202236232869PubTator, text miningPubMed
Profound Effects of Dexamethasone on the Immunological State, Synthesis and Secretion Capacity of Human Testicular Peritubular Cells.Cells202236231125PubTator, text miningPubMed
Prediction of hepatocellular carcinoma prognosis and immunotherapeutic effects based on tryptophan metabolism-related genes.Cancer Cell Int202236217206PubTator, text miningPubMed
Optimizing the use of lenvatinib in combination with pembrolizumab in patients with advanced endometrial carcinoma.Front Oncol202236212444PubTator, text miningPubMed
Bioavailability of nanomaterials: bridging the gap between nanostructures and their bioactivity.Natl Sci Rev202236196113PubTator, text miningPubMed
Possible agent for COVID-19 treatment: Rifampicin.World J Virol202236188747PubTator, text miningPubMed
Characterization of a Trametes versicolor aflatoxin B1-degrading enzyme (TV-AFB1D) and its application in the AFB1 degradation of contaminated rice in situ.Front Microbiol202236187979PubTator, text miningPubMed
Correlation of Tryptophan Metabolic Pathway with Immune Activation and Chemosensitivity in Patients with Lung Adenocarcinoma.J Oncol202236185621PubTator, text miningPubMed
Drug clearance by aldehyde oxidase: can we avoid clinical failure?Xenobiotica202236170034PubTator, text miningPubMed
Racial/Ethnic Differences in the Pharmacokinetics of Antipsychotics: Focusing on East Asians.J Pers Med202236143147PubTator, text miningPubMed
Nicotinamide N-Methyltransferase as Promising Tool for Management of Gastrointestinal Neoplasms.Biomolecules202236139012PubTator, text miningPubMed
CYP2A6 gene polymorphism and severity of coronary atherosclerosis in Indonesian male smokers: A pilot study.Medicine (Baltimore)202236123879PubTator, text miningPubMed
Single-cell atlas of human liver development reveals pathways directing hepatic cell fates.Nat Cell Biol202236109670PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/316/papers?page=18